Nystatin NDC 50090-1740

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-1740Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-1740Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-1740-0	50090174000	60 mL in 1 BOTTLE, GLASS (50090-1740-0)Marketed from Mar 12, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nystatin
Generic name (nonproprietary): nystatin
Active ingredients: Nystatin — 100000 [USP'U]/mL
Dosage form: Suspension
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062512
Marketing start: Apr 15, 1995
Listing expires: Dec 31, 2026
Other FDA classes: Polyenes (Chemical structure)
Identifiers: Product ID 50090-1740_8d9b172d-a817-43b1-9cd9-24243b311f28SPL ID 8d9b172d-a817-43b1-9cd9-24243b311f28SPL set ID e069d495-7f1a-4970-8f4d-aa93d124b3fcRxCUI 312055UNII BDF1O1C72E
Pharmacologic class: Polyene Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090174000 followed by a unit qualifier and the quantity

Package 50090-1740-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 4, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Nystatin Oral Suspension is indicated for the treatment of candidiasis in the oral cavity.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 062512

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 062512
Product	Strength	Form · route	Labeler	Product NDC
Nystatin Oral Suspensionnystatin	Nystatin 100000 [USP'U]/mL	SuspensionOral	Xttrium Laboratories, Inc.	0116-4026